although analysis of 24-h timed urine collections revealed that doxorubicin was the predominant anthracycline , the extent of urinary elimination showed considerable interpatient variation ( 1.0-52.5 % of the infused dose/24-h period on the short-term protocol and 5.3-57.2 % /24-h period on the long-term protocol ) .
C0013089
doxorubicin
C0212922
period